According to a study published by Insure Insights, the sleep apnea devices market is anticipated to grow at a CAGR of 7.9% during the forecast period. Sleep apnea is a sleep disorder in which people stop breathing in their sleep or breathe become shallow or completely stop once unconscious. Repeated blockage of the upper airway causes apnea that prevents the brain and lungs from getting oxygen, thereby resulting in heavy snoring or sometimes even choking. Sleep apnea can be caused by multiple factors such as endocrine disorders, obesity, large tonsils, certain genetic syndrome, premature birth, neuromuscular disorders, etc. Sleep apnea left untreated can lead to other fatal consequences like heart attacks, diabetes, cancer, glaucoma, cognitive and behavioral disorders. One of the common methods used for the treatment of sleep apnea is continuous positive airway pressure device (CPAP). CPAP is a mask that fits over the nose/mouth and gently blows air into the airway and aids to keep it open during sleep. This method of treatment has proven to be highly effective.

Top Driver: Rising Prevalence and Growing Geriatric Population 

The growing prevalence of sleep apnea is the prominent factor driving the sleep apnea diagnosis market. According to a study published by NCBI, the prevalence of obstructive sleep apnea (OSA) defined at an apnea-hypopnea index (AHI) ≥5 was a mean of 22% (range, 9-37%) in men and 17% (range, 4-50%) in women in eleven published epidemiological studies published between 1993 and 2013. With the increasing age and obesity, OSA is more prevalent in men than in women. This has encouraged the government to take initiatives regarding sleep disorders.

In addition to this, the growing geriatric population facing sleep apnea disorder is rising in recent years. Obstructive sleep apnea has found to be a common disorder in the geriatric population, affecting around 13 – 32% of people above 65 years of age. According to the WHO statistics, the world’s population aged 60 years and above is expected to reach 2 billion by 2050. This population group is more prone to suffer from obstructive sleep apnea as their muscles easily weaken up due to aging and lead to the narrowing of the airway.

Actigraphy Devices Anticipated to Create Lucrative Market During the Forecast Period

Based on the diagnostic devices, the sleep apnea devices market has been segmented into pulse oximeters, actigraphy devices, and polysomnography devices. Actigraphy devices hold a significant market share. Actigraphy devices, also known as actometer, are a device worn on the wrist to monitor and records the movement and sleeping/waking patterns over an extended time period. The recorded data can be displayed and scored manually or downloaded to a computer for further analysis.

Actigraphy is less invasive, inexpensive, and miniatured technology has resulted in the growing popularity of the actometer. Added benefits such as the device allow to follow-up once the treatment has begun and analyses the sleep pattern over an extended period of time. Further, it facilitates non-intrusive 24-hours at home and does not require special installation skills and techniques.

Based on the therapeutic devices, the market has been segmented into Positive Airway Pressure Devices (PAP), oxygen devices, oral appliances, and others. Positive Airway Pressure (PAP) devices estimated to witness significant growth owing to growing demand for portable, efficient and superior sleep apnea devices. Besides, presence of favorable insurance coverage for treatment of sleep apnea and other sleep disorders will further propel PAP devices market growth.

Rising Sleep Apnea Incidences in the United States to Benefit North America Market

North America is the dominating region holding the largest market share in the sleep apnea devices market. Countries such as the United States is the major contributor to the growth of sleep apnea devices market in North America. The primary factor owing to the growth of the market is the rising prevalence of sleep apnea disorder in the U.S. According to the American Sleep Apnea Association, sleep apnea is one of the significant health issues in the United States. It has been estimated that 22 million Americans suffer from sleep apnea, among which 80 percent of the cases are moderate and severe obstructive sleep apnea undiagnosed. Further, the growing chronic disorders and geriatric population in North America are other significant factors stimulating the sleep apnea devices market.

Players to Focus on Technological Advancements to Introduce Innovative Products  

Key players operating in the sleep apnea devices market are Curative Medical Inc., Philips Respironics, ResMed, Fisher & Paykel Healthcare, Cadwell Laboratories, and Invacare Corporation.

Fisher & Paykel Healthcare Corporation Ltd.: In February 2020, Fisher & Paykel Healthcare Corporation Ltd introduced F&P Evora, a new nasal mask for the treatment of obstructive sleep apnea (OSA). F&P Evora is a compact nasal mask that fits comfortably under the nose. The mask features CapFit headgear, which is designed to be put on like a baseball cap in one simple and intuitive movement.

Philips Respironics: In September 2019, Royal Philips introduced a prescription sleep position therapy device called NightBalance to help people with positional obstructive sleep apnoea (OSA). The device is designed to deliver positional therapy by sending gentle vibrations to encourage patients to changes their sleeping positions in order to prevent apnoeas. The device provides a mask-free alternative to current positional OSA therapies. It comes with wireless connectivity and a mobile app to track its use.

Scope of the Report

By Diagnostic Devices

• Pulse oximeters
• Actigraphy devices
• Polysomnography Devices

By Therapeutic Devices

• Oxygen Devices
• Positive Airways Pressure Devices
• Oral Appliances
• Others

By Region

• North America
• Europe
• Asia Pacific
• SAMEA

Key Reasons to Purchase this Report

1. It provides a technological development map over time to understand the growth rate of the industry.
2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
3. It renders definite analysis for changing competitive dynamics.
4. It builds a seven-year estimate based on how the market is predicted to grow.